- Visibility 74 Views
- Downloads 24 Downloads
- Permissions
- DOI 10.18231/j.ijcbr.2019.074
-
CrossMark
- Citation
Vitamin D levels in type 2 diabetics on insulin sensitizers vis a vis in newly diagnosed diabetics
- Author Details:
-
Rajiv Nehra *
-
Manju
Objective: Vitamin D mediates a pivotal role and major risk factor in the development of type 2 diabetes
mellitus mediated by alteration in the insulin sensitivity or b -cell physiological function, or both. The
present study was carried out to analyze the serum levels of vitamin D3 in type 2 diabetics on insulin
sensitizers and in newly diagnosed diabetics.
Materials and Methods: In this 100 subjects were enrolled and they are divided in two groups, newly
diagnosed type 2 diabetics and type 2 diabetics on insulin sensitizers. Serum vitamin D3 was measured by
chemiluminescence microparticle immunoassay. Fasting plasma glucose level was measured by hexokinase
method using the Dimension clinical chemistry system.
Results: In this study, the mean serum vitamin D3 level was significantly (p<0>
type 2 diabetes mellitus subjects as compared to the type 2 diabetics on insulin sensitizers (10.332.56 vs
20.89 3.24 ng/ml)s. Further, in patients who were on treatment with insulin sensitizers showed normal
level of Vitamin D3 and Fasting blood glucose. Conclusion: Thus, vitamin D3 deficiency is the hallmark
status in diabetes mellitus and maintenance of type 2 DM with insulin sensitizers may ameliorate the
vitamin D deficiency.
Keywords: Type 2 Diabetes, Blood glucose level, Vitamin D.
References
- Weiss S. Bacterial components plus vitamin D3: the ultimate solution to the asthma (autoimmune disease) epidemic?J Allergy Clin Immunol. 2011;127:1128–1130.
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1153.
- Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus.Pediatrics. 2005;116:473–480.
- Holick MF, Chen TC. Vitamin D deficiency: A worldwide problem with health consequences.Am J Clin Nut. 2008;87:1080–1086.
- Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patient.Int J Cli Pract. 2003;57:258–
- Sesti G. Pathophysiology of insulin resistance.Best Pract Res Clin Endocrinol. 2006;20:665–679.
- Gonzalez-Clemente X, F JMBV, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus.Diabetes Obes Metab. 2008;10:185–197.
- Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, et al. Expression of 25- hydroxyvitamin D3-1-hydroxylase in pancreatic islets.J Steroid Biochem Mol Biol. 2004;89:121–125.
- Chiu KC, Chu A, Go W, Saad MF. Hypovitaminosis D is associated with insulin resistance and -cell dysfunction.Am J Clin Nut. 2004;79:820–825.
- Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: Metabolism.Endocrinol Metab Clin North Am. 2010;39:243–253.
- Sung CC, Liao MT, Lu KC, Wu CC. Role of Vitamin D in insulin resistance.Biomed Res Int. 2012;.
- Tracy S, Mazen J. The role of vitamin D deficiency in the pathogenesis of type 2 diabetes mellitus.Eur J Clin Nut Metab. 2010;5:155–165.
- Targher G, Bertolini L, Padovani R, Zenari L, Scala L, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima- media thickness among type diabetic patients.Clin Endocrinol. 2006;65:593–597.
- Chiu KC, Chu A, Go W, Saad MF. Hypovitaminosis D is associated with insulin resistance and -cell dysfunction.Am J Clin Nut. 2004;79:820–845.
- Sur A, Priya G. Association of serum Vitamin D level with Glycemic Status in Patients of Type 2 Diabetes Mellitus.Endocrinol Metab Syndr. 2017;6:268–268.
- Penckofer S, Wallis DE, Emanuele MA. Vitamin D3 and diabetes: let the sunshine in.Diabetes Educ. 2008;34:39–40.
- Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D3, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey.Diabetes Care. 2004;27:2813–2821.
- Calvo-Romero JM, Lozano JMR. Vitamin D levels in patients with type 2 Diabetes Mellitus.J Investig Med. 2015;63(8):921–924.
- Zoppini G, Galletti A, Targher G, Brangani C, Pichiri I, Negri C. Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients.PLoS One. 2013;8(12):82733–82733.
- Sur A, Priya G. Association of serum Vitamin D level with Glycemic status in patients of type 2 Diabetes Mellitus.Endocrinol Metab Syndr. 2017;6(3):268–268. Nehra and Manju / International Journal of Clinical Biochemistry and Research 2019;6(3):340–343343 Author biography Rajiv NehraAssociate Professor ManjuDental Surgeon
How to Cite This Article
Vancouver
Nehra R, Manju . Vitamin D levels in type 2 diabetics on insulin sensitizers vis a vis in newly diagnosed diabetics [Internet]. Int J Clin Biochem Res. 2019 [cited 2025 Oct 15];6(3):340-343. Available from: https://doi.org/10.18231/j.ijcbr.2019.074
APA
Nehra, R., Manju, (2019). Vitamin D levels in type 2 diabetics on insulin sensitizers vis a vis in newly diagnosed diabetics. Int J Clin Biochem Res, 6(3), 340-343. https://doi.org/10.18231/j.ijcbr.2019.074
MLA
Nehra, Rajiv, Manju, . "Vitamin D levels in type 2 diabetics on insulin sensitizers vis a vis in newly diagnosed diabetics." Int J Clin Biochem Res, vol. 6, no. 3, 2019, pp. 340-343. https://doi.org/10.18231/j.ijcbr.2019.074
Chicago
Nehra, R., Manju, . "Vitamin D levels in type 2 diabetics on insulin sensitizers vis a vis in newly diagnosed diabetics." Int J Clin Biochem Res 6, no. 3 (2019): 340-343. https://doi.org/10.18231/j.ijcbr.2019.074